Pharmanova Specialties Profile
Key Indicators
- Authorised Capital ₹ 5.75 Cr
- Paid Up Capital ₹ 5.18 Cr
- Company Age 11 Year, 1 Day
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.15 Cr
About Pharmanova Specialties
Pharmanova Specialties Private Limited (PSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 31 January 2014 and has a history of 11 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.75 Cr and a paid-up capital of Rs 5.18 Cr.
The company has closed loans amounting to ₹7.15 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Maneesh Sapte, Vinay Sapte, and Prasenjit Mukherjee serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2014PTC252718
-
Company No.
252718
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Jan 2014
-
Date of AGM
11 Jul 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pharmanova Specialties?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maneesh Sapte
|
Additional Director | 20-Aug-2019 | Current |
|
Vinay Sapte
|
Additional Director | 20-Aug-2019 | Current |
|
Prasenjit Mukherjee
|
Director | 24-Oct-2019 | Current |
Financial Performance of Pharmanova Specialties.
Pharmanova Specialties Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmanova Specialties?
In 2023, Pharmanova Specialties had a promoter holding of 99.94% and a public holding of 0.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Phaarmasia LimitedManeesh Sapte and Vinay Sapte are mutual person
-
Ergos Life Sciences Private LimitedVinay Sapte is a mutual person
-
Svizera Health Remedies LlpManeesh Sapte and Vinay Sapte are mutual person
-
Maneesh Pharmaceuticals LimitedManeesh Sapte and Vinay Sapte are mutual person
-
Adhrit Education LlpManeesh Sapte and Vinay Sapte are mutual person
-
Svizera Pharma Private Limited
Maneesh Sapte and Vinay Sapte are mutual person
Charges (Loans)
₹0
₹7.15 Cr
Charges Breakdown by Lending Institutions
- Others : 7.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jul 2015 | Others | ₹7.15 Cr | Satisfied |
How Many Employees Work at Pharmanova Specialties?
Pharmanova Specialties has a workforce of 299 employees as of Jan 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmanova Specialties, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmanova Specialties's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
